- Report
- March 2026
- 244 Pages
India
From €4381EUR$4,850USD£3,802GBP
- Report
- March 2026
- 176 Pages
China
From €4381EUR$4,850USD£3,802GBP
- Report
- March 2026
- 150 Pages
Canada
From €4381EUR$4,850USD£3,802GBP
- Report
- March 2026
- 210 Pages
Germany
From €4381EUR$4,850USD£3,802GBP
- Report
- December 2024
- 150 Pages
Global
From €4381EUR$4,850USD£3,802GBP
Aspergillosis is a type of fungal infection caused by the Aspergillus fungus. It can affect the lungs, sinuses, and other organs. Treatment for aspergillosis typically involves antifungal medications. The Aspergillosis Drug market is a subset of the larger Infectious Diseases Drugs market, which includes drugs used to treat a variety of bacterial, viral, and fungal infections. Aspergillosis drugs are used to treat a variety of forms of the infection, including allergic bronchopulmonary aspergillosis, chronic pulmonary aspergillosis, and invasive aspergillosis. These drugs are typically administered orally or intravenously.
Some companies in the Aspergillosis Drug market include Merck & Co., Pfizer, GlaxoSmithKline, AstraZeneca, and Novartis. Show Less Read more